15 Jul 2022
According to a new study, published in The Lancet Healthy Longevity, testosterone therapy in men with hypogonadism does not increase their risk of cardiovascular complications. This is in line with existing advice from the European Medicines Agency and the UK Society for Endocrinology’s treatment guidelines.
NEW Research SIG
07 Jan 2025
ISE selects Bioscientifica as its association management provider
01 Jan 2025
Division Chief of Endocrinology
01 Jan 2025
Society members recognised in New Year Honours List
01 Jan 2025